Open AccessSelf-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era
Author(s) -
Gaetana Sterrantino,
Santoro,
Bartolozzi,
Trotta,
Zaccarelli
Publication year - 2012
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s31385
Subject(s) - raltegravir , efavirenz , medicine , regimen , maraviroc , ritonavir , emtricitabine , integrase inhibitor , reverse transcriptase inhibitor , darunavir , rilpivirine , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , virology
To analyze self-reported adherence to antiretroviral regimens containing ritonavir-boosted protease inhibitors, nonnucleoside reverse transcriptase inhibitors (NNRTI), raltegravir, and maraviroc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom